GlassScriptPhysician profile
Eric R Freedman
NPI 1316976152
$5,874.62
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,009 · 2020: $3,907 · 2021: $725 · 2022: $234.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $4,058.13 | 2019-2020 | |
| Boston Scientific Corporation | $643.56 | 2020 | |
| Teleflex LLC | $405.00 | 2021-2022 | |
| 180 Medical, INC. | $225.54 | 2019-2022 | |
| Procept Biorobotics Corporation | $194.42 | 2021 | |
| Urogen Pharma, INC. | $85.11 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.00 | 2021 | |
| Healthtronics Stone Solutions, LLC | $46.21 | 2020-2021 | |
| Astellas Pharma US INC | $35.59 | 2021 | |
| Travere Therapeutics, INC. | $28.24 | 2021 | |
| Ferring Pharmaceuticals INC. | $24.49 | 2019 | |
| Dornier Medtech America, INC | $19.84 | 2020 | |
| Lumenis, INC | $18.50 | 2021 | |
| Myovant Sciences INC. | $14.99 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Freedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.